Skip to main content

Myomo, Inc.

MYO
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001369290

In the last 90 days, Myomo, Inc. insiders filed 0 open-market purchases and 3 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $12.7M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Myomo, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of MYO: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7682+6
Shares16.0M19.2M+3.24M (+20.3%)
Value$76.7M$41.5M−$35.3M (−46.0%)

New holders (28)

Institutions that held Myomo, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to MYO in Q2 2025
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP151,755$327.8K0.00%
Nuveen, LLC119,681$258.5K0.00%
Graham Capital Management, L.P.62,879$135.8K0.00%
XTX Topco Ltd62,130$134.2K0.01%
Bank of New York Mellon Corp58,802$127.0K0.00%
Lazard Asset Management LLC45,643$98.0K0.00%
New York State Common Retirement Fund45,100$97.4K0.00%
Gsa Capital Partners LLP34,624$75.0K0.01%
Rhumbline Advisers29,934$64.7K0.00%
Two Sigma Advisers, LP21,300$46.0K0.00%
LPL Financial LLC18,623$40.2K0.00%
Intech Investment Management LLC17,787$38.4K0.00%
Mirae Asset Global ETFs Holdings Ltd.17,750$38.3K0.00%
Invesco Ltd.17,113$37.0K0.00%
Wells Fargo & Company16,824$36.3K0.00%
Price T Rowe Associates Inc16,564$36.0K0.00%
Verition Fund Management LLC16,300$35.2K0.00%
R Squared Ltd13,195$28.5K0.02%
Prelude Capital Management, LLC12,200$26.4K0.00%
Alliancebernstein L.P.12,000$25.9K0.00%
Citigroup Inc11,559$25.0K0.00%
Legal & General Group Plc3,624$7.79K0.00%
Ameritas Investment Partners, Inc.3,324$7.18K0.00%
California State Teachers Retirement System2,031$4.39K0.00%
Amalgamated Bank1,112$2.00K0.00%
FMR LLC341$7370.00%
Raymond James Financial Inc103$2220.00%
Sterling Capital Management LLC79$1710.00%

Sold out (22)

Institutions that held Myomo, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.